Antibody & Protein Sales
In this product category, you will find reports about global sales of therapeutic antibodies and proteins for a given calendar year. The reports provide a compilation of the sales data of originator recombinant therapeutic proteins and antibodies in a tabular format. Sales data were obtained from company publications and refer to branded products originating from companies based in regulated markets.
Showing all 8 resultsSorted by latest
-
March of 20252024 Sales of Therapeutic Antibodies, Proteins, Biosimilars, Gene & Cell Therapy and Therapeutic RNA€ 130.00
-
March of 20242023 sales data of originator therapeutic proteins and antibodies, selected biosimilars and other biologic drug modalities (gene & cell therapy, RNA)€ 130.00
-
March of 2023Sales data of originator therapeutic proteins and antibodies & selected biosimilar antibodies and proteins and other biologics in 2022€ 120.00
-
March of 2022This report provides a compilation of the sales data of originator recombinant therapeutic proteins and antibodies in the calendar year 2021€ 100.00
-
March of 2021Compilation of the global sales data of branded originator recombinant therapeutic proteins and antibodies, of selected biosimilars and other novel biologics in the calendar year 2020€ 100.00
-
March of 2020Compilation of the global sales data of branded originator recombinant therapeutic proteins and antibodies and of selected biosimilars in the calendar year 2019€ 90.00
-
March of 2019This report provides a compilation of the global sales data of branded originator recombinant therapeutic proteins and antibodies in the calendar year 2018.€ 80.00
-
March of 2018€ 80.00